Ads
related to: is strontium bad for kidneys and heart health problems
Search results
Results From The WOW.Com Content Network
Kidney toxicity [5] associated with kidney failure; associated with development of cancer, particularly of the urinary tract, known carcinogen [8] [9] Atractylate Atractylis gummifera: Liver damage, [3] nausea, vomiting, epigastric and abdominal pain, diarrhoea, anxiety, headache and convulsions, often followed by coma [10]
Strontium is a chemical element; it has symbol Sr and atomic number 38. An alkaline earth metal, it is a soft silver-white yellowish metallic element that is highly chemically reactive. The metal forms a dark oxide layer when it is exposed to air.
Naturally occurring strontium is nonradioactive and nontoxic at levels normally found in the environment, but 90 Sr is a radiation hazard. [4] 90 Sr undergoes β − decay with a half-life of 28.79 years and a decay energy of 0.546 MeV distributed to an electron, an antineutrino, and the yttrium isotope 90 Y, which in turn undergoes β − decay with a half-life of 64 hours and a decay energy ...
The use of strontium ranelate is restricted because of increased risk of venous thromboembolism, pulmonary embolism and serious cardiovascular disorders, including myocardial infarction. [8] In postmenopausal women, the selective estrogen receptor modulator raloxifene is occasionally administered instead of bisphosphonates.
This condition causes fever, rapid breathing coupled with rapid heart rate, labored breathing and severe shortness of breath. Other effects include diaphoresis, chest pain, and persistent dry cough, all of which may result in weight loss, anorexia and may also lead to right-side heart enlargement and heart disease in advanced cases.
If this happens, it's a pretty good sign that your kidneys are healthy.
Strontium-90 is a by-product of nuclear fission, present in nuclear fallout. The 1986 Chernobyl nuclear accident contaminated a vast area with 90 Sr. [ 6 ] It causes health problems, as it substitutes for calcium in bone , preventing expulsion from the body.
On 21 February 2014 the European Medicine Agency recommended that strontium ranelate remain available with restrictions relative to patients with existing heart disease. [4] In 2017, a large study of over 280,000 British and Spanish patients found no increased risk of venous thromboembolism in users of strontium ranelate compared to alendronate ...